Direct-acting antivirals trigger a favorable, sustained virological response in patients with chronic hepatitis C infections and hepatocellular carcinoma
Korean J Intern Med. 2021 Mar;36(2):286-287. doi: 10.3904/kjim.2021.078. Epub 2021 Feb 25.NO ABSTRACTPMID:33725434 | DOI:10.3904/kjim.2021.078
Source: The Korean Journal of Internal Medicine - Category: Internal Medicine Authors: Won Sohn Source Type: research
More News: Cancer & Oncology | Carcinoma | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Internal Medicine | Liver Cancer | Virology